Solubility-Limiting Bioavailability

Solubility-limiting bioavailability describes absorption limitation from inadequate pharmaceutical dissolution. Poorly soluble drugs exhibit variable absorption depending on food and pH. Formulation enhancement strategies improve bioavailability. Supersaturation approaches temporarily overcome solubility limits. Precipitation during GI transit reduces absorption.

Bioequivalence assessment accounts for solubility effects. Formulation optimisation maximises bioavailability. Regulatory submissions address solubility limitation impact. Post-approval monitoring confirms bioavailability maintenance. Emerging formulation technologies overcome solubility barriers.